FIELD: chemistry.
SUBSTANCE: present invention relates to novel compounds of formula
,
where Y denotes a group of formula , in which: R' is selected from hydrogen atoms, (C1-C6) alkoxy or phenoxy, the aromatic ring of which is optionally substituted with one or more halogen atoms; R denotes a hydrogen atom; n equals 0; X denotes isoquinolinyl. The invention also relates to use of the compound of formula (I) and a pharmaceutical composition based on said compound.
EFFECT: obtaining novel compounds having vanilloid receptor type 1 antagonist properties.
5 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
BIARYL CARBOXYARYL AMIDES AS TYPE 1 VANILLOID MODULATORS | 2007 |
|
RU2468020C2 |
TRPVI AGONISTS, PREPARATIONS CONTAINING SAID AGONISTS AND USE THEREOF | 2005 |
|
RU2379282C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
NOVEL POLYUNSATURATED COMPOUNDS, METHOD OF THEIR OBTAINING AND COMPOSITIONS WHICH CONTAIN THEM | 2006 |
|
RU2466988C2 |
SULPHUR-CONTAINING RESORCINOL DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND COSMETIC APPLICATION | 2010 |
|
RU2539589C2 |
METHOD FOR PREPARING RETINAL OR ADDUCT (COMPLETE-E)-RETINAL WITH HYDROQUINONE AND INTERMEDIATE SUBSTANCES | 2002 |
|
RU2318805C2 |
INDOLYLMALEIMIDE DERIVATIVES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AND PHARMACEUICAL COMPOSITION FOR TREATMENT OR PREVENTION OF T-LYMPHOCYTE AND/OR "ПКС"- MEDIATED DISORDERS OR DISEASES | 2003 |
|
RU2340610C2 |
METHOD OF PRODUCING HIGH-PURITY LONG-CHAIN CYCLOHEXENONE ALCOHOL | 2017 |
|
RU2729186C2 |
PRODUCING METHOD OF LONG-CHAIN ALCOHOL OF HIGH PURITY CYCLOHEXENONE | 2017 |
|
RU2745062C2 |
MACROCYCLIC HEPATITIS C VIRUS INIHBITORS | 2006 |
|
RU2437886C2 |
Authors
Dates
2012-04-10—Published
2007-07-02—Filed